cells and immortal, HGPRT myeloma cells. They are created to produce monoclonal antibodies in biotechnology. inhibitsde novo synthesisof nucleic acids, killing myeloma cells that cannot switch over to the salvage pathway, due to lack of HRPT1. The plasm